MediPharm Labs Corp. announced that board member Shelley Potts will step down on December 31, 2025, and Michael Bumby will assume the role effective January 1, 2026. Bumby previously served as a board member and CFO of VIVO Cannabis Inc., which MediPharm acquired in 2023, and has senior experience in global pharmaceutical companies.

Potts Out, Bumby in on MediPharm Labs Board

Dec 11, 2025

Source:

Mg Magazine Newswire

MG Magazine

*TORONTO* — MediPharm Labs Corp. board of directors member Shelley Potts
will be stepping down effective December 31, 2025. Michael Bumby will
replace her effective January 1, 2026.

Bumby previously served on the Board and was Chief Financial Officer at
VIVO Cannabis Inc., which MediPharm acquired in 2023. In addition to his
experience in the cannabis sector, he has held senior leadership roles in
global pharmaceutical companies, providing strategic and financial
oversight across highly regulated markets.

Recent Reviews

Fade Co.’s Boston Tea Party: A Declaration of Independence from Boring Vapes

As we stand on the eve of the Fourth of July, what better way to celebrate American independence than with a strain literally named after the spark that lit the fuse? Fade Co.’s Boston Tea Party All-in-One live resin disposable is currently available at Story Dispensary locations across Maryland (including Waldorf), and it feels like a cheeky act of defiance against boring vapes everywhere...

Cookies BernieHana Butter & Tequila Sunrise Dual Chamber Terp Vape - Takoma Wellness Center

This Dual Chamber 3-in-1 Cookies cannabis terp vape, currently available at Takoma Wellness Center, introduces an intriguing level of cho...

RHYTHM Cannabis' Afternoon Delight 4 Strain Review

I was excited to try one of the newest drops from RHYTHM, Afternoon Delight 4 and I knew that first impressions were going to mean everything. With this being a GMO cross, I was already expecting some funk, but I was pleasantly surprised with how many other notes were present...

2 3 4 5

Menu